UNSPSC 51281614: Netilmicin

This classification denotes an aminoglycoside antibiotic with the molecular formula C21H41N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4O5J85GJJB, chemically known as o-(2,6-diamino-2,3,4,6-tetradesoxy-alpha-glycero-4-hexenopyranosyl-(1-4)-o-(3-desoxy-4-c-methyl-3-methylamino-beta-l-arabinopyranosyl-(1-6)-2-desoxy-n1-ethyl-d-streptamin but generally known as netilmicin, which bears US NIH Compound Identifier 41859.

UNSPSC 51281614 Netilmicin is a Commodity code in the pharmaceutical products category, but the recent state and local procurement activity recorded under this code does not reflect netilmicin procurement. Instead, the opportunities tagged to this code cover other pharmaceutical products—chiefly antibiotic tablets (doxycycline hyclate and ciprofloxacin hydrochloride) and naloxone with drug deactivation systems—suggesting a data-tagging misalignment between the code's nominal scope and the work state and local agencies are actually sourcing. State and local health departments and county health systems use pharmaceutical commodity codes to procure bulk pharmaceutical inventories through piggyback contracts (leveraging existing master agreements via cooperative purchasing consortiums such as MMCAP Infuse) and through competitive sealed bidding. Issuing bodies include state departments of public health and county health authorities.

Recent activity spans Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026 (bid number 26-482DPH-PREPD-B-53392) for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets, totaling $2,999,999.11 over the contract life including renewals; this was a completed award under an Invitation for Bid process, not an open solicitation. Seminole County, Florida released an IFB on June 30, 2026 (IFB 60459723LAS) with a response deadline of July 26, 2023 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building in Sanford, Florida; vendors were required to include shipping and delivery costs and comply with E-Verify and drug-free workplace certification. The code shows limited recent activity and poor alignment between its pharmaceutical focus and the actual products being solicited.